The breast cancer and lung cancer results were not just "very good"...they were outstanding. BP's know this. They also know what is happening with the IST's as they are all open label. There will be a deal and it will be a good one.
Carboat, you wrote: "Very good results, very small study. Just saying if pphm wants full price they have not delivered enough proof to offset their negative baggage."
Of course, your opinion will carry itself unresolved until the window of time PPHM allotted for entering into a Pharma partnering for the Phase 3 trial has elapsed. I figure that the February 2014 time frame is about how long long investors need to wait. We shall see.